🇺🇸 FDA
Patent

US 10555997

Antigens and vaccines directed against human enteroviruses

granted A61KA61K2039/5256A61K2039/5258

Quick answer

US patent 10555997 (Antigens and vaccines directed against human enteroviruses) held by SENTINEXT THERAPEUTICS Sdn Bhd expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SENTINEXT THERAPEUTICS Sdn Bhd
Grant date
Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/5256, A61K2039/5258, A61K2039/70, A61K39/12